Understanding and Applying Discount Rates for Precise Biopharma Valuations Selecting the appropriate discount rate is essential for pharmaceutical and biotechnology valuations. The discount rate is one of the key drivers…
Finessing Pharma and Biotech Product Strategies in the Post-Inflation Reduction Act Era The recent passage of the Inflation Reduction Act (IRA) introduces sweeping changes for the biopharmaceutical industry through new…
Key Factors in Venture Capital Valuation of Healthcare and Life Sciences Startups Valuing early-stage healthcare and life sciences startups presents unique challenges due to their lack of revenue, high-risk profiles,…
Leveraging EBITDA Multiples for Accurate Pharma Company Valuations Determining the valuation of pharmaceutical and biotechnology companies is a crucial exercise to inform high-impact decisions including organic investments and prioritization, licensing…
Leveraging Biotech Valuation Multiples for Accurate Biopharma Company Valuations Valuation of biotech companies, assets, and programs is often required for a multitude of purposes. The biotech valuation multiples is a…
Key Strategies for Conducting Efficacious Competitor Analysis in the Pharma Industry Competitor analysis is frequently performed in the pharma industry for a variety of reasons, and a robust knowledge of…
Criteria and Strategies for Choosing the Right Comparable Companies in Biotech Valuation When valuing a private or public biotech company using market multiples, one of the most critical first steps…
Proven Strategies to Speed Up Biotech and Pharma Partnering & Out-Licensing Deals Are you frustrated with the slow and time-consuming process of out-licensing biopharma assets? The good news is that…
Enhancing Pharma Competitive Intelligence Through Primary Research and Expert CI Interviews
Leveraging Sales Force Competitive Intelligence for Strategic Advantage in Pharma and Medical Devices Sales force intelligence, which is technically a subset of field force intelligence, is an example of benchmarking.…